Johnson & Johnson Reports Q3 2021 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. ISRG
6. TSLA
7. SMCI
8. GOOGL
9. RTX
10. COF

Go back to Johnson & Johnson Reports Q3 2021 Results

Johnson & Johnson (JNJ) Reports a Beat-and-Raise 3Q, Analyst Positive

October 19, 2021 7:53 AM EDT

Johnson & Johnson (NYSE: JNJ) reported better-than-expected 3Q results today and left its vaccine guidance unchanged.

The company reported Q3 EPS of $2.60 to top the analyst estimate of $2.36. However, revenue for the quarter came in at $23.3 billion to miss the consensus estimate of $23.74 billion. The company left its COVID-19 vaccine sales target unchanged at $2.5... More

Johnson & Johnson (JNJ) Tops Q3 EPS by 24c, Raises FY Guidance

October 19, 2021 6:27 AM EDT

(Updated - October 19, 2021 6:28 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.60, $0.24 better than the analyst estimate of $2.36. Revenue for the quarter came in at $23.3 billion versus the consensus estimate of $23.74 billion.

GUIDANCE:

Johnson & Johnson sees 2021 EPS of $9.77-$9.82,... More